{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:30:23Z","timestamp":1792593023897,"version":"4.5.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Risk assessment models (RAMs) for venous thromboembolism (VTE) and bleeding in hospitalized medical patients inform appropriate use of thromboprophylaxis. Our aim was to use a novel approach for selecting risk factors for VTE and bleeding to be included in RAMs. First, we used the results of a systematic review of all candidate factors. Second, we used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence for the identified factors. Third, we using a structured approach to select factors to develop the RAMs, by building on clinical and methodological expertise. The expert panel made judgments on whether to include, potentially include, or exclude risk factors, according to domains of the GRADE approach and the Delphi method. The VTE RAM included age &amp;gt;60 years, previous VTE, acute infections, immobility, acute paresis, active malignancy, critical illness, and known thrombophilia. The bleeding RAM included age \u226565 years, renal failure, thrombocytopenia, active gastroduodenal ulcers, hepatic disease, recent bleeding, and critical illness. We identified acute infection as a factor that was not considered in widely used RAMs. Also, we identified factors that require further research to confirm or refute their importance in a VTE RAM (eg, D-dimer). We excluded autoimmune disease which is included in the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) bleeding RAM. Our results also suggest that sex, malignancy, and use of central venous catheters (factors in the IMPROVE bleeding RAM) require further research. In conclusion, our study presents a novel approach to systematically identifying and assessing risk factors to be included or further explored during RAM development.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001937","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T15:42:38Z","timestamp":1592235758000},"page":"2557-2566","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-1697","authenticated-orcid":false,"given":"Andrea J.","family":"Darzi","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-4246","authenticated-orcid":false,"given":"Samer G.","family":"Karam","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Spencer","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Spyropoulos","sequence":"first","affiliation":[{"name":"The Donald and Barbara Zucker School of Medicine, Hofstra\/Northwell, Hempstead, NY;"},{"name":"Department of Medicine, Northwell Health, Lenox Hill Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-5461","authenticated-orcid":false,"given":"Lawrence","family":"Mbuagbaw","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, Canada;"},{"name":"Centre for Development of Best Practices in Health (CDBPH), Yaound\u00e9 Central Hospital, Yaound\u00e9, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-2705","authenticated-orcid":false,"given":"Scott C.","family":"Woller","sequence":"first","affiliation":[{"name":"Department of Medicine, Intermountain Medical Center, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8824-4410","authenticated-orcid":false,"given":"Neil A.","family":"Zakai","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-3493","authenticated-orcid":false,"given":"Michael B.","family":"Streiff","sequence":"first","affiliation":[{"name":"Division of Hematology, Departments of Medicine and Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Gould","sequence":"first","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6143","authenticated-orcid":false,"given":"Mary","family":"Cushman","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Charide","sequence":"first","affiliation":[{"name":"American University of Beirut (AUB) GRADE Center, Clinical Research Institute, AUB, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Etxeandia-Ikobaltzeta","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-3616","authenticated-orcid":false,"given":"Federico","family":"Germini","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"},{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-9491","authenticated-orcid":false,"given":"Marta","family":"Rigoni","sequence":"first","affiliation":[{"name":"Healthcare Research and Innovation Program, Heath Technology Assessment Unit, Fondazione Bruno Kessler, Trento, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0931-7851","authenticated-orcid":false,"given":"Arnav","family":"Agarwal","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"},{"name":"Faculty of Medicine, University of Toronto, Toronto, ON, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-3711","authenticated-orcid":false,"given":"Rami Z.","family":"Morsi","sequence":"first","affiliation":[{"name":"American University of Beirut (AUB) GRADE Center, Clinical Research Institute, AUB, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"},{"name":"American University of Beirut (AUB) GRADE Center, Clinical Research Institute, AUB, Beirut, Lebanon;"},{"name":"Department of Internal Medicine, AUB, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-8766","authenticated-orcid":false,"given":"Alfonso","family":"Iorio","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-8479","authenticated-orcid":false,"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre,"},{"name":"Department of Health Research Methods, Evidence, and Impact, and"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"issue":"1","key":"2020061810392526300_B1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1076029616677802","article-title":"Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients: A Systematic Review","volume":"24","author":"Ye","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"2020061810392526300_B2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jth.13942","article-title":"Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis","volume":"16","author":"Chan","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2020061810392526300_B3","doi-asserted-by":"crossref","first-page":"e5595","DOI":"10.1136\/bmj.e5595","article-title":"Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes","volume":"346","author":"Hemingway","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"2020061810392526300_B4","doi-asserted-by":"crossref","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Med"},{"issue":"4","key":"2020061810392526300_B5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1160\/TH16-08-0631","article-title":"Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review","volume":"117","author":"Stuck","year":"2017","journal-title":"Thromb Haemost"},{"issue":"1","key":"2020061810392526300_B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11239-012-0780-0","article-title":"Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review","volume":"35","author":"Huang","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"2020061810392526300_B7","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2020061810392526300_B8","first-page":"533","article-title":"Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients","volume":"3","author":"Rocha","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"2020061810392526300_B9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2019.04.015","article-title":"Hospitalist assessment of venous thromboembolism and bleeding risk: a survey study","volume":"178","author":"Cruden","year":"2019","journal-title":"Thromb Res"},{"issue":"20","key":"2020061810392526300_B10","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.2019003603","article-title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","volume":"135","author":"Darzi","year":"2020","journal-title":"Blood"},{"key":"2020061810392526300_B11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2017.09.159","article-title":"Clinical conundrums in antithrombotic therapy management: a Delphi Consensus panel","volume":"249","author":"Colonna","year":"2017","journal-title":"Int J Cardiol"},{"key":"2020061810392526300_B12","unstructured":"Centers for Disease Control and Prevention\n          . The 2015 Healthcare-Associated Venous Thromboembolism Prevention Challenge Champions. 2020. https:\/\/www.cdc.gov\/ncbddd\/dvt\/ha-vte-challenge.html. Accessed 29 January 2020."},{"issue":"11","key":"2020061810392526300_B13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2020061810392526300_B14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2020061810392526300_B15","doi-asserted-by":"crossref","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"2020061810392526300_B16","volume-title":"Analysis of the future: the Delphi method","author":"Helmer","year":"1967"},{"key":"2020061810392526300_B17","unstructured":"GRADEpro GDT\n          . GRADEpro Guideline Development Tool.2020. www.gradepro.org. Accessed 29 January 2020."},{"key":"2020061810392526300_B18","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2020061810392526300_B19","first-page":"i2089","volume-title":"BMJ","author":"Alonso-Coello","year":"2016"},{"key":"2020061810392526300_B20","unstructured":"SurveyMonkey\n          . Get answers with surveys 1999-2018. https:\/\/www.surveymonkey.com. Accessed 15 August 2018."},{"issue":"14","key":"2020061810392526300_B21","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/sim.6080","article-title":"Meta-analysis and aggregation of multiple published prediction models","volume":"33","author":"Debray","year":"2014","journal-title":"Stat Med"},{"key":"2020061810392526300_B22","article-title":"The RAND\/UCLA appropriateness method user\u2019s manual","author":"Fitch","year":"2001"},{"key":"2020061810392526300_B23","unstructured":"Hsu\n              C-C\n            , SandfordBA. The Delphi Technique: Making Sense of Consensus. Semantic Scholar. 2007https:\/\/www.semanticscholar.org\/paper\/The-Delphi-Technique%3A-Making-Sense-of-Consensus-Hsu-Sandford\/edd0a804fccb2a7587f785bf255a52a61fc23284. Accessed 3 January 2020."},{"issue":"4","key":"2020061810392526300_B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/phar.1218","article-title":"Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease","volume":"33","author":"Barclay","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2020061810392526300_B25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11239-010-0548-3","article-title":"Early stroke-related deep venous thrombosis: risk factors and influence on outcome","volume":"32","author":"Bembenek","year":"2011","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2020061810392526300_B26","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.25011\/cim.v34i1.15106","article-title":"Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China","volume":"34","author":"Fan","year":"2011","journal-title":"Clin Invest Med"},{"issue":"5","key":"2020061810392526300_B27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjmed.2015.10.027","article-title":"Assessing the caprini score for risk assessment of venous thromboembolism in hospitalized medical patients","volume":"129","author":"Grant","year":"2016","journal-title":"Am J Med"},{"issue":"10","key":"2020061810392526300_B28","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/01.STR.0000140741.13279.4f","article-title":"Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging","volume":"35","author":"Kelly","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"2020061810392526300_B29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1160\/TH14-03-0239","article-title":"External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)","volume":"112","author":"Mahan","year":"2014","journal-title":"Thromb Haemost"},{"issue":"8","key":"2020061810392526300_B30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1253\/circj.CJ-08-0990","article-title":"Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan","volume":"73","author":"Ota","year":"2009","journal-title":"Circ J"},{"issue":"6","key":"2020061810392526300_B31","doi-asserted-by":"crossref","first-page":"e001152","DOI":"10.1161\/JAHA.114.001152","article-title":"External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system","volume":"3","author":"Rosenberg","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2020061810392526300_B32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jhm.888","article-title":"Risk factor model to predict venous thromboembolism in hospitalized medical patients","volume":"6","author":"Rothberg","year":"2011","journal-title":"J Hosp Med"},{"issue":"3","key":"2020061810392526300_B33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"issue":"2","key":"2020061810392526300_B34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11239-012-0720-z","article-title":"The incidence of venous thromboembolism following stroke and its risk factors in eastern China","volume":"34","author":"Yi","year":"2012","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"2020061810392526300_B35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jth.12147","article-title":"Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study","volume":"11","author":"Zakai","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2020061810392526300_B36","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1538-7836.2004.00991.x","article-title":"Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score","volume":"2","author":"Zakai","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2020061810392526300_B37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.5551\/jat.43653","article-title":"Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model","volume":"25","author":"Zhou","year":"2018","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"2020061810392526300_B38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"5","key":"2020061810392526300_B39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.thromres.2013.08.013","article-title":"Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population","volume":"132","author":"Mahan","year":"2013","journal-title":"Thromb Res"},{"key":"2020061810392526300_B40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2017.08.005","article-title":"Identifying predictors for bleeding in hospitalized cancer patients: a cohort study","volume":"158","author":"Patell","year":"2017","journal-title":"Thromb Res"},{"issue":"11","key":"2020061810392526300_B41","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2020061810392526300_B42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjmed.2011.06.004","article-title":"Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients","volume":"124","author":"Woller","year":"2011","journal-title":"Am J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2557\/1745288\/advancesadv2020001937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2557\/1745288\/advancesadv2020001937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T15:32:50Z","timestamp":1592494370000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/12\/2557\/460921\/Risk-models-for-VTE-and-bleeding-in-medical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001937","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}